Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Baxter International    BAX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
61.71(c) 62.01(c) 62.53(c) 62.82(c) 63.65(c) Last
2 264 863 2 280 863 1 459 995 2 837 203 2 715 096 Volume
+0.42% +0.49% +0.84% +0.46% +1.32% Change
More quotes
Financials ($)
Sales 2017 10 492 M
EBIT 2017 1 669 M
Net income 2017 1 144 M
Finance 2017 655 M
Yield 2017 0,93%
Sales 2018 10 927 M
EBIT 2018 1 891 M
Net income 2018 1 334 M
Finance 2018 1 377 M
Yield 2018 1,10%
P/E ratio 2017 32,72
P/E ratio 2018 26,08
EV / Sales2017 3,20x
EV / Sales2018 3,01x
Capitalization 34 229 M
More Financials
Company
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug... 
More about the company
Surperformance© ratings of Baxter International
Trading Rating : Investor Rating :
More Ratings
Latest news on BAXTER INTERNATIONAL
10/16 BAXTER INTERNATIONAL : to Present at the Credit Suisse 26th Annual Healthcare Co..
10/16 BAXTER INTERNATIONAL : Provides Update on Puerto Rico Recovery Status Post Hurri..
10/13 DELIVERING ON OUR MISSION : Recovery Efforts in Puerto Rico
10/12 BAXTER INTERNATIONAL : Provides Update on Puerto Rico Recovery Status Post Hurri..
10/12 BAXTER INTERNATIONAL : Enrolls First Patients in U.S. and Colombia Clinical Tria..
10/10 BAXTER INTERNATIONAL : Initiates Voluntary Nationwide Recall of One Shipment of ..
10/05 BAXTER INTERNATIONAL : Launches First 3-in-1 Set for Use in Continuous Renal Rep..
10/05 BAXTER INTERNATIONAL : Initiates Voluntary Nationwide Recall of One Shipment of ..
10/04 BAXTER INTERNATIONAL : Enrolls First Patients in U.S. and Colombia Clinical Tria..
10/04 BAXTER INTERNATIONAL : Enrolls First Patients in U.S., Colombia Clinical Trials ..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
10/16$BAX Baxter to Present at the Credit Suisse 26th Annual Healthcare Conference.. 
10/16Baxter International Inc. $BAX Stake Lessened by Navellier & Associates I.. 
10/16Baxter International downgraded by Zacks Investment Research to hold.  
10/16Baxter International given $68.00 PT by Cowen and Company. hold rating.  
10/15SWING TRADE ALERT: Recent $BAX technical alerts: Three Weeks Tight plus 3 mor.. 
More tweets
Qtime:64
News from SeekingAlpha
10/13 FDA assisting Baxter with restart of Puerto Rico minibag production
10/11 DENTSPLY : An Example Of Misaligned Incentives Leading To A Bad Outcome
10/09 First meeting of new FDA advisory committee this week
10/04 Edwards Lifesciences Is A Buy - Cramer's Lightning Round (10/3/17)
10/03 Has Medtronic's Decline Made It A Buy?
Chart BAXTER INTERNATIONAL
Duration : Period :
Baxter International Technical Analysis Chart | BAX | US0718131099 | 4-Traders
Technical analysis trends BAXTER INTERNATIONAL
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 67,2 $
Spread / Average Target 7,0%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Vice President-Operations
Catherine R. Smith Chief Financial Officer, Director & Executive VP
Paul E. Martin Chief Information Officer & Vice President
Marcus Schabacker Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL41.68%34 229
MEDTRONIC PLC9.60%105 753
ZIMMER BIOMET HOLDINGS INC15.99%24 203
C R BARD INC43.94%23 501
HOYA CORPORATION27.19%21 566
TERUMO CORP8.09%15 821